The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
Zidavi is recommended by the Infectious Disease Society of America
Subscribe To Our Newsletter & Stay Updated
